Clinical Trials Directory

Trials / Unknown

UnknownNCT04213287

Multimodal Analgesia Methods in Patients Undergoing IPACK Block in Knee Arthroplasty

Evaluation of Multimodal Analgesia Methods in Patients Who Underwent IPACK Block in Total Knee Arthroplasty

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Ankara Diskapi Training and Research Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

A comparison of two pain control methods - the combination of Adductor Canal Block (ACB)/Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) versus the Periarticular Injection (PAI)/ Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) - in patients undergoing total knee arthroplasty. dexketoprofen and paracetamol will be added to both groups and multimodal analgesia will be applied. Primary outcome is NRS pain scores with ambulation on postoperative day one (24 hours post-block administration).

Detailed description

Postoperative pain after total knee arthroplasty is serious and difficult to management. Multimodal analgesia recommended for the pain management. For these reasons, we planned a study involving two multimodal analgesia regimens. Patients who will undergo total knee arthroplasty will receive preemptive oral analgesic (dexketofrofen) 1 hour before the operation. Surgery will be initiated after spinal anesthesia is applied to the patients. Two pain control methods - the combination of Adductor Canal Block (ACB)/Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) versus the Periarticular Injection (PAI)/ IPACK- will be applied at the end of the surgery. dexketoprofenand paracetamol will be added to both groups and multimodal analgesia will be applied. Primary outcome is NRS pain scores with ambulation on postoperative day one (24 hours post-block administration).

Conditions

Interventions

TypeNameDescription
DRUGDexketoprofen TrometamolDrug: Dexketoprofen Trometamol oral tablet
OTHERspinal anesthesiaDrug: heavy bupivacaine 2,5 ml 0,5%
OTHERIPACKDrug: bupivacaine 20 ml 0,025%
OTHERPAIDrug: bupivacaine 30 ml 0,025%
OTHERAdductor canal blockDrug: bupivacaine 20 ml 0,025%

Timeline

Start date
2019-12-23
Primary completion
2020-03-01
Completion
2020-03-15
First posted
2019-12-30
Last updated
2019-12-30

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04213287. Inclusion in this directory is not an endorsement.